KIAA0280 Inhibitors
Chemical inhibitors of KIAA0280 can modulate its function through various mechanisms depending on the kinase pathways they target. SB-216763, a selective inhibitor of glycogen synthase kinase 3 (GSK-3), can prevent the phosphorylation of KIAA0280, assuming it is a substrate for this kinase. This process is critical as phosphorylation often regulates the activity and function of proteins. Similarly, Y-27632 targets the Rho-associated protein kinase (ROCK), which plays a significant role in actin cytoskeleton organization. If KIAA0280 is associated with actin dynamics, the inhibition of ROCK by Y-27632 can alter actin organization and potentially inhibit the function of KIAA0280. In the case of LY294002, an inhibitor of phosphoinositide 3-kinases (PI3K), the effect on KIAA0280 could be indirect. By inhibiting PI3K, LY294002 can affect the activity of downstream signaling components that KIAA0280 may require for its function.
In addition to these, PD98059 and U0126, both inhibitors of mitogen-activated protein kinase kinase (MEK), can inhibit the functional activity of KIAA0280 if it is regulated by the MAPK/ERK pathway. These inhibitors prevent the phosphorylation or activation of KIAA0280 by extracellular signal-regulated kinases (ERK), which are downstream in the pathway. SP600125, which inhibits c-Jun N-terminal kinase (JNK), and SB-203580, targeting p38 MAP kinase, can also affect KIAA0280 function if it is involved in pathways regulated by these kinases. These pathways are crucial for cellular responses such as stress, apoptosis, and cytokine production. Furthermore, wortmannin and rapamycin, inhibitors of PI3K and mammalian target of rapamycin (mTOR) respectively, can lead to the downregulation of KIAA0280 function by hindering the activation of downstream signaling pathways essential for a wide range of cellular processes, including growth and metabolism. Lastly, Bisindolylmaleimide I and PP2, specific inhibitors of protein kinase C (PKC) and Src family kinases, respectively, can interrupt the signaling cascades that KIAA0280 may be involved in, thus inhibiting its function by preventing necessary phosphorylation events or protein interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Inhibits glycogen synthase kinase 3 (GSK-3), a kinase that phosphorylates and thereby regulates a number of proteins. By inhibiting GSK-3, SB-216763 can prevent the phosphorylation of KIAA0280, assuming that KIAA0280 is a substrate for GSK-3, leading to its functional inhibition as phosphorylation can be critical for KIAA0280's activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Acts as a selective inhibitor of Rho-associated protein kinase (ROCK), a regulator of the actin cytoskeleton. If KIAA0280 is involved in actin cytoskeleton dynamics, the inhibition of ROCK by Y-27632 can lead to changes in actin organization that could inhibit the function of KIAA0280 by altering the cellular architecture it relies on. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in signaling pathways that regulate a variety of cellular processes. Inhibition of PI3K by LY294002 can lead to reduced activity of downstream effectors that may be necessary for KIAA0280 function, thereby inhibiting KIAA0280 indirectly. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Specifically inhibits mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. If KIAA0280's function is regulated by the ERK pathway, then PD98059 can inhibit KIAA0280 by preventing its phosphorylation or activation by ERK, assuming that this is a necessary step for KIAA0280's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which is implicated in the regulation of apoptosis and cell proliferation. Inhibition of JNK by SP600125 could lead to the functional inhibition of KIAA0280 if KIAA0280 plays a role in these JNK-regulated pathways, by altering the phosphorylation status or activity of proteins that KIAA0280 interacts with or regulates. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Specifically inhibits MEK, another kinase in the MAPK/ERK pathway. By inhibiting MEK, U0126 can inhibit the functional activity of KIAA0280 if KIAA0280 is regulated by the ERK pathway and relies on MEK activity for its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, which is involved in stress responses and cytokine production. If KIAA0280's function is linked to p38 MAP kinase signaling, then the inhibition of this kinase by SB-203580 could lead to functional inhibition of KIAA0280 by disrupting the signaling processes it depends on. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent inhibitor of PI3K which can prevent the activation of downstream signaling pathways that regulate cellular growth and metabolism. If KIAA0280 is regulated by PI3K or its downstream effectors, wortmannin can inhibit KIAA0280 by preventing these downstream signaling events from occurring. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to and inhibits the mammalian target of rapamycin (mTOR), a key regulator of cell growth and proliferation. If KIAA0280's function is dependent on mTOR signaling, then rapamycin can inhibit KIAA0280 by preventing the downstream signaling events typically promoted by mTOR activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A specific inhibitor of protein kinase C (PKC), which is involved in controlling numerous cellular functions including cell cycle and apoptosis. If KIAA0280 interacts with or is regulated by PKC, then Bisindolylmaleimide I can inhibit KIAA0280 by preventing PKC-mediated signaling events, assuming that these events are necessary for KIAA0280's function. | ||||||